Bevacizumab enhances chemo for non-small cell lung cancer

Gespeichert in:

Format:	E-Artikel
Sprache:	Englisch

Erschienen:	2007

Schlagwörter:	Lung Cancer Treatment Effect Bevacizumab Cell Lung Cancer Gemcitabine

Anmerkung:	© Adis International Ltd 2007

Übergeordnetes Werk:	Enthalten in: Inpharma weekly - Auckland : ADIS internat., 1975, 1577(2007), 1 vom: März, Seite 18-18
Übergeordnetes Werk:	volume:1577 ; year:2007 ; number:1 ; month:03 ; pages:18-18

Links:	Volltext

DOI / URN:	10.2165/00128413-200715770-00049

Katalog-ID:	SPR035278382

Internformat


LEADER	01000caa a22002652 4500
001	SPR035278382
003	DE-627
005	20230519234630.0
007	cr uuu---uuuuu
008	201007s2007 xx \|\|\|\|\|o 00\| \|\|eng c
024	7		\|a 10.2165/00128413-200715770-00049 \|2 doi
035			\|a (DE-627)SPR035278382
035			\|a (SPR)00128413-200715770-00049-e
040			\|a DE-627 \|b ger \|c DE-627 \|e rakwb
041			\|a eng
245	1	0	\|a Bevacizumab enhances chemo for non-small cell lung cancer
264		1	\|c 2007
336			\|a Text \|b txt \|2 rdacontent
337			\|a Computermedien \|b c \|2 rdamedia
338			\|a Online-Ressource \|b cr \|2 rdacarrier
500			\|a © Adis International Ltd 2007
650		4	\|a Lung Cancer \|7 (dpeaa)DE-He213
650		4	\|a Treatment Effect \|7 (dpeaa)DE-He213
650		4	\|a Bevacizumab \|7 (dpeaa)DE-He213
650		4	\|a Cell Lung Cancer \|7 (dpeaa)DE-He213
650		4	\|a Gemcitabine \|7 (dpeaa)DE-He213
773	0	8	\|i Enthalten in \|t Inpharma weekly \|d Auckland : ADIS internat., 1975 \|g 1577(2007), 1 vom: März, Seite 18-18 \|w (DE-627)373977859 \|w (DE-600)2127607-9 \|x 2230-6056 \|7 nnns
773	1	8	\|g volume:1577 \|g year:2007 \|g number:1 \|g month:03 \|g pages:18-18
856	4	0	\|u https://dx.doi.org/10.2165/00128413-200715770-00049 \|z lizenzpflichtig \|3 Volltext
912			\|a GBV_USEFLAG_A
912			\|a SYSFLAG_A
912			\|a GBV_SPRINGER
912			\|a SSG-OLC-PHA
912			\|a GBV_ILN_20
912			\|a GBV_ILN_206
912			\|a GBV_ILN_2005
912			\|a GBV_ILN_2009
912			\|a GBV_ILN_2011
912			\|a GBV_ILN_2055
912			\|a GBV_ILN_2111
912			\|a GBV_ILN_4305
951			\|a AR
952			\|d 1577 \|j 2007 \|e 1 \|c 03 \|h 18-18

Indexfelder

matchkey_str	article:22306056:2007----::eaiuaehneceoonnmlc
hierarchy_sort_str	2007
publishDate	2007
allfields	10.2165/00128413-200715770-00049 doi (DE-627)SPR035278382 (SPR)00128413-200715770-00049-e DE-627 ger DE-627 rakwb eng Bevacizumab enhances chemo for non-small cell lung cancer 2007 Text txt rdacontent Computermedien c rdamedia Online-Ressource cr rdacarrier © Adis International Ltd 2007 Lung Cancer (dpeaa)DE-He213 Treatment Effect (dpeaa)DE-He213 Bevacizumab (dpeaa)DE-He213 Cell Lung Cancer (dpeaa)DE-He213 Gemcitabine (dpeaa)DE-He213 Enthalten in Inpharma weekly Auckland : ADIS internat., 1975 1577(2007), 1 vom: März, Seite 18-18 (DE-627)373977859 (DE-600)2127607-9 2230-6056 nnns volume:1577 year:2007 number:1 month:03 pages:18-18 https://dx.doi.org/10.2165/00128413-200715770-00049 lizenzpflichtig Volltext GBV_USEFLAG_A SYSFLAG_A GBV_SPRINGER SSG-OLC-PHA GBV_ILN_20 GBV_ILN_206 GBV_ILN_2005 GBV_ILN_2009 GBV_ILN_2011 GBV_ILN_2055 GBV_ILN_2111 GBV_ILN_4305 AR 1577 2007 1 03 18-18
spelling	10.2165/00128413-200715770-00049 doi (DE-627)SPR035278382 (SPR)00128413-200715770-00049-e DE-627 ger DE-627 rakwb eng Bevacizumab enhances chemo for non-small cell lung cancer 2007 Text txt rdacontent Computermedien c rdamedia Online-Ressource cr rdacarrier © Adis International Ltd 2007 Lung Cancer (dpeaa)DE-He213 Treatment Effect (dpeaa)DE-He213 Bevacizumab (dpeaa)DE-He213 Cell Lung Cancer (dpeaa)DE-He213 Gemcitabine (dpeaa)DE-He213 Enthalten in Inpharma weekly Auckland : ADIS internat., 1975 1577(2007), 1 vom: März, Seite 18-18 (DE-627)373977859 (DE-600)2127607-9 2230-6056 nnns volume:1577 year:2007 number:1 month:03 pages:18-18 https://dx.doi.org/10.2165/00128413-200715770-00049 lizenzpflichtig Volltext GBV_USEFLAG_A SYSFLAG_A GBV_SPRINGER SSG-OLC-PHA GBV_ILN_20 GBV_ILN_206 GBV_ILN_2005 GBV_ILN_2009 GBV_ILN_2011 GBV_ILN_2055 GBV_ILN_2111 GBV_ILN_4305 AR 1577 2007 1 03 18-18
allfields_unstemmed	10.2165/00128413-200715770-00049 doi (DE-627)SPR035278382 (SPR)00128413-200715770-00049-e DE-627 ger DE-627 rakwb eng Bevacizumab enhances chemo for non-small cell lung cancer 2007 Text txt rdacontent Computermedien c rdamedia Online-Ressource cr rdacarrier © Adis International Ltd 2007 Lung Cancer (dpeaa)DE-He213 Treatment Effect (dpeaa)DE-He213 Bevacizumab (dpeaa)DE-He213 Cell Lung Cancer (dpeaa)DE-He213 Gemcitabine (dpeaa)DE-He213 Enthalten in Inpharma weekly Auckland : ADIS internat., 1975 1577(2007), 1 vom: März, Seite 18-18 (DE-627)373977859 (DE-600)2127607-9 2230-6056 nnns volume:1577 year:2007 number:1 month:03 pages:18-18 https://dx.doi.org/10.2165/00128413-200715770-00049 lizenzpflichtig Volltext GBV_USEFLAG_A SYSFLAG_A GBV_SPRINGER SSG-OLC-PHA GBV_ILN_20 GBV_ILN_206 GBV_ILN_2005 GBV_ILN_2009 GBV_ILN_2011 GBV_ILN_2055 GBV_ILN_2111 GBV_ILN_4305 AR 1577 2007 1 03 18-18
allfieldsGer	10.2165/00128413-200715770-00049 doi (DE-627)SPR035278382 (SPR)00128413-200715770-00049-e DE-627 ger DE-627 rakwb eng Bevacizumab enhances chemo for non-small cell lung cancer 2007 Text txt rdacontent Computermedien c rdamedia Online-Ressource cr rdacarrier © Adis International Ltd 2007 Lung Cancer (dpeaa)DE-He213 Treatment Effect (dpeaa)DE-He213 Bevacizumab (dpeaa)DE-He213 Cell Lung Cancer (dpeaa)DE-He213 Gemcitabine (dpeaa)DE-He213 Enthalten in Inpharma weekly Auckland : ADIS internat., 1975 1577(2007), 1 vom: März, Seite 18-18 (DE-627)373977859 (DE-600)2127607-9 2230-6056 nnns volume:1577 year:2007 number:1 month:03 pages:18-18 https://dx.doi.org/10.2165/00128413-200715770-00049 lizenzpflichtig Volltext GBV_USEFLAG_A SYSFLAG_A GBV_SPRINGER SSG-OLC-PHA GBV_ILN_20 GBV_ILN_206 GBV_ILN_2005 GBV_ILN_2009 GBV_ILN_2011 GBV_ILN_2055 GBV_ILN_2111 GBV_ILN_4305 AR 1577 2007 1 03 18-18
allfieldsSound	10.2165/00128413-200715770-00049 doi (DE-627)SPR035278382 (SPR)00128413-200715770-00049-e DE-627 ger DE-627 rakwb eng Bevacizumab enhances chemo for non-small cell lung cancer 2007 Text txt rdacontent Computermedien c rdamedia Online-Ressource cr rdacarrier © Adis International Ltd 2007 Lung Cancer (dpeaa)DE-He213 Treatment Effect (dpeaa)DE-He213 Bevacizumab (dpeaa)DE-He213 Cell Lung Cancer (dpeaa)DE-He213 Gemcitabine (dpeaa)DE-He213 Enthalten in Inpharma weekly Auckland : ADIS internat., 1975 1577(2007), 1 vom: März, Seite 18-18 (DE-627)373977859 (DE-600)2127607-9 2230-6056 nnns volume:1577 year:2007 number:1 month:03 pages:18-18 https://dx.doi.org/10.2165/00128413-200715770-00049 lizenzpflichtig Volltext GBV_USEFLAG_A SYSFLAG_A GBV_SPRINGER SSG-OLC-PHA GBV_ILN_20 GBV_ILN_206 GBV_ILN_2005 GBV_ILN_2009 GBV_ILN_2011 GBV_ILN_2055 GBV_ILN_2111 GBV_ILN_4305 AR 1577 2007 1 03 18-18
language	English
source	Enthalten in Inpharma weekly 1577(2007), 1 vom: März, Seite 18-18 volume:1577 year:2007 number:1 month:03 pages:18-18
sourceStr	Enthalten in Inpharma weekly 1577(2007), 1 vom: März, Seite 18-18 volume:1577 year:2007 number:1 month:03 pages:18-18
format_phy_str_mv	Article
institution	findex.gbv.de
topic_facet	Lung Cancer Treatment Effect Bevacizumab Cell Lung Cancer Gemcitabine
isfreeaccess_bool	false
container_title	Inpharma weekly
publishDateDaySort_date	2007-03-01T00:00:00Z
hierarchy_top_id	373977859
id	SPR035278382
language_de	englisch
fullrecord	<?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>01000caa a22002652 4500</leader><controlfield tag="001">SPR035278382</controlfield><controlfield tag="003">DE-627</controlfield><controlfield tag="005">20230519234630.0</controlfield><controlfield tag="007">cr uuu---uuuuu</controlfield><controlfield tag="008">201007s2007 xx \|\|\|\|\|o 00\| \|\|eng c</controlfield><datafield tag="024" ind1="7" ind2=" "><subfield code="a">10.2165/00128413-200715770-00049</subfield><subfield code="2">doi</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-627)SPR035278382</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(SPR)00128413-200715770-00049-e</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-627</subfield><subfield code="b">ger</subfield><subfield code="c">DE-627</subfield><subfield code="e">rakwb</subfield></datafield><datafield tag="041" ind1=" " ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Bevacizumab enhances chemo for non-small cell lung cancer</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="c">2007</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="a">Text</subfield><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="a">Computermedien</subfield><subfield code="b">c</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="a">Online-Ressource</subfield><subfield code="b">cr</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="500" ind1=" " ind2=" "><subfield code="a">© Adis International Ltd 2007</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Lung Cancer</subfield><subfield code="7">(dpeaa)DE-He213</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Treatment Effect</subfield><subfield code="7">(dpeaa)DE-He213</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Bevacizumab</subfield><subfield code="7">(dpeaa)DE-He213</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Cell Lung Cancer</subfield><subfield code="7">(dpeaa)DE-He213</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Gemcitabine</subfield><subfield code="7">(dpeaa)DE-He213</subfield></datafield><datafield tag="773" ind1="0" ind2="8"><subfield code="i">Enthalten in</subfield><subfield code="t">Inpharma weekly</subfield><subfield code="d">Auckland : ADIS internat., 1975</subfield><subfield code="g">1577(2007), 1 vom: März, Seite 18-18</subfield><subfield code="w">(DE-627)373977859</subfield><subfield code="w">(DE-600)2127607-9</subfield><subfield code="x">2230-6056</subfield><subfield code="7">nnns</subfield></datafield><datafield tag="773" ind1="1" ind2="8"><subfield code="g">volume:1577</subfield><subfield code="g">year:2007</subfield><subfield code="g">number:1</subfield><subfield code="g">month:03</subfield><subfield code="g">pages:18-18</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://dx.doi.org/10.2165/00128413-200715770-00049</subfield><subfield code="z">lizenzpflichtig</subfield><subfield code="3">Volltext</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_USEFLAG_A</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SYSFLAG_A</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_SPRINGER</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SSG-OLC-PHA</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_20</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_206</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2005</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2009</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2011</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2055</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2111</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4305</subfield></datafield><datafield tag="951" ind1=" " ind2=" "><subfield code="a">AR</subfield></datafield><datafield tag="952" ind1=" " ind2=" "><subfield code="d">1577</subfield><subfield code="j">2007</subfield><subfield code="e">1</subfield><subfield code="c">03</subfield><subfield code="h">18-18</subfield></datafield></record></collection>
ppnlink_with_tag_str_mv	@@773@@(DE-627)373977859
format	electronic Article
delete_txt_mv	keep
collection	springer
remote_str	true
illustrated	Not Illustrated
issn	2230-6056
topic_title	Bevacizumab enhances chemo for non-small cell lung cancer Lung Cancer (dpeaa)DE-He213 Treatment Effect (dpeaa)DE-He213 Bevacizumab (dpeaa)DE-He213 Cell Lung Cancer (dpeaa)DE-He213 Gemcitabine (dpeaa)DE-He213
topic	misc Lung Cancer misc Treatment Effect misc Bevacizumab misc Cell Lung Cancer misc Gemcitabine
spellingShingle	misc Lung Cancer misc Treatment Effect misc Bevacizumab misc Cell Lung Cancer misc Gemcitabine Bevacizumab enhances chemo for non-small cell lung cancer
topic_unstemmed	misc Lung Cancer misc Treatment Effect misc Bevacizumab misc Cell Lung Cancer misc Gemcitabine
topic_browse	misc Lung Cancer misc Treatment Effect misc Bevacizumab misc Cell Lung Cancer misc Gemcitabine
format_facet	Elektronische Aufsätze Aufsätze Elektronische Ressource
format_main_str_mv	Text Zeitschrift/Artikel
carriertype_str_mv	cr
hierarchy_parent_title	Inpharma weekly
hierarchy_parent_id	373977859
hierarchy_top_title	Inpharma weekly
isfreeaccess_txt	false
familylinks_str_mv	(DE-627)373977859 (DE-600)2127607-9
title	Bevacizumab enhances chemo for non-small cell lung cancer
ctrlnum	(DE-627)SPR035278382 (SPR)00128413-200715770-00049-e
title_full	Bevacizumab enhances chemo for non-small cell lung cancer
journal	Inpharma weekly
journalStr	Inpharma weekly
lang_code	eng
isOA_bool	false
recordtype	marc
publishDateSort	2007
contenttype_str_mv	txt
container_start_page	18
container_volume	1577
format_se	Elektronische Aufsätze
doi_str_mv	10.2165/00128413-200715770-00049
title_sort	bevacizumab enhances chemo for non-small cell lung cancer
title_auth	Bevacizumab enhances chemo for non-small cell lung cancer
abstract	© Adis International Ltd 2007
abstractGer	© Adis International Ltd 2007
abstract_unstemmed	© Adis International Ltd 2007
collection_details	GBV_USEFLAG_A SYSFLAG_A GBV_SPRINGER SSG-OLC-PHA GBV_ILN_20 GBV_ILN_206 GBV_ILN_2005 GBV_ILN_2009 GBV_ILN_2011 GBV_ILN_2055 GBV_ILN_2111 GBV_ILN_4305
container_issue	1
title_short	Bevacizumab enhances chemo for non-small cell lung cancer
url	https://dx.doi.org/10.2165/00128413-200715770-00049
remote_bool	true
ppnlink	373977859
mediatype_str_mv	c
isOA_txt	false
hochschulschrift_bool	false
doi_str	10.2165/00128413-200715770-00049
up_date	2024-07-03T14:02:27.134Z
_version_	1803566812641624064
fullrecord_marcxml	<?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>01000caa a22002652 4500</leader><controlfield tag="001">SPR035278382</controlfield><controlfield tag="003">DE-627</controlfield><controlfield tag="005">20230519234630.0</controlfield><controlfield tag="007">cr uuu---uuuuu</controlfield><controlfield tag="008">201007s2007 xx \|\|\|\|\|o 00\| \|\|eng c</controlfield><datafield tag="024" ind1="7" ind2=" "><subfield code="a">10.2165/00128413-200715770-00049</subfield><subfield code="2">doi</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-627)SPR035278382</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(SPR)00128413-200715770-00049-e</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-627</subfield><subfield code="b">ger</subfield><subfield code="c">DE-627</subfield><subfield code="e">rakwb</subfield></datafield><datafield tag="041" ind1=" " ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Bevacizumab enhances chemo for non-small cell lung cancer</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="c">2007</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="a">Text</subfield><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="a">Computermedien</subfield><subfield code="b">c</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="a">Online-Ressource</subfield><subfield code="b">cr</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="500" ind1=" " ind2=" "><subfield code="a">© Adis International Ltd 2007</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Lung Cancer</subfield><subfield code="7">(dpeaa)DE-He213</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Treatment Effect</subfield><subfield code="7">(dpeaa)DE-He213</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Bevacizumab</subfield><subfield code="7">(dpeaa)DE-He213</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Cell Lung Cancer</subfield><subfield code="7">(dpeaa)DE-He213</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Gemcitabine</subfield><subfield code="7">(dpeaa)DE-He213</subfield></datafield><datafield tag="773" ind1="0" ind2="8"><subfield code="i">Enthalten in</subfield><subfield code="t">Inpharma weekly</subfield><subfield code="d">Auckland : ADIS internat., 1975</subfield><subfield code="g">1577(2007), 1 vom: März, Seite 18-18</subfield><subfield code="w">(DE-627)373977859</subfield><subfield code="w">(DE-600)2127607-9</subfield><subfield code="x">2230-6056</subfield><subfield code="7">nnns</subfield></datafield><datafield tag="773" ind1="1" ind2="8"><subfield code="g">volume:1577</subfield><subfield code="g">year:2007</subfield><subfield code="g">number:1</subfield><subfield code="g">month:03</subfield><subfield code="g">pages:18-18</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://dx.doi.org/10.2165/00128413-200715770-00049</subfield><subfield code="z">lizenzpflichtig</subfield><subfield code="3">Volltext</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_USEFLAG_A</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SYSFLAG_A</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_SPRINGER</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SSG-OLC-PHA</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_20</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_206</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2005</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2009</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2011</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2055</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2111</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4305</subfield></datafield><datafield tag="951" ind1=" " ind2=" "><subfield code="a">AR</subfield></datafield><datafield tag="952" ind1=" " ind2=" "><subfield code="d">1577</subfield><subfield code="j">2007</subfield><subfield code="e">1</subfield><subfield code="c">03</subfield><subfield code="h">18-18</subfield></datafield></record></collection>
score	7.4016542

Nicht das Richtige dabei?

Schreiben Sie uns!

Bevacizumab enhances chemo for non-small cell lung cancer

Nicht das Richtige dabei?

Zugang & Verfügbarkeit

Vorhandene Bände

Nicht das Richtige dabei?